Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
03/30/1999 | US5889155 Carbohydrate-directed cross-linking reagents |
03/30/1999 | US5889153 Protein or polypeptide, method for producing the same and intermediate compound therefor |
03/30/1999 | US5888968 Solubilizing agent selected from sodium chloride, isocitrate ions, glutamate, succinate ions, imidazole and sodium dodecyl sulfate; hypertonic; antiinflammatory and anticoagulants |
03/30/1999 | US5888833 Antigens recognized by antibodies to rheumatoid arthritis, their preparation and their applications |
03/30/1999 | US5888813 Monoclonal antibodies against human pancreatic islet cells |
03/30/1999 | US5888775 Peptide synthesis and purification by fusion to penI protein or precipitation effective portion thereof |
03/30/1999 | US5888753 Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof |
03/30/1999 | US5888750 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin |
03/30/1999 | US5888365 Electrophoretic separation |
03/30/1999 | CA1340472C Universal t-cell epitope derived from p. faciparum circumsporosoite protein |
03/25/1999 | WO1999014189A1 Amino acid derivatives |
03/25/1999 | WO1999013896A1 Attenuated vif dna immunization cassettes for genetic vaccines |
03/25/1999 | WO1998055509A3 Two human dnaj-like proteins |
03/25/1999 | WO1998051819A9 Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
03/25/1999 | WO1998051780A3 Method for increasing yields or recombinant proteins |
03/25/1999 | WO1998050068A9 Mass spectrometry of colonization factors |
03/25/1999 | CA2304125A1 Attenuated vif dna immunization cassettes for genetic vaccines |
03/24/1999 | EP0903337A1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
03/24/1999 | EP0902834A1 Stable avidin composition and methods using same |
03/24/1999 | EP0705279A4 Topologically segregated, encoded solid phase libraries |
03/24/1999 | CN1211578A PEG-inerferon conjugates |
03/23/1999 | US5886154 Chromatographic method for high yield purification and viral inactivation of antibodies |
03/23/1999 | US5886104 Biochemical immobilized ethylene-styrene graft copolmer, use for protein solid-phase synthesis |
03/23/1999 | US5885841 System and methods for qualitatively and quantitatively comparing complex admixtures using single ion chromatograms derived from spectroscopic analysis of such admixtures |
03/23/1999 | US5885837 Very large scale immobilized polymer synthesis using mechanically directed flow paths |
03/23/1999 | US5885782 Microbiocide oligopeptide mixture comprising at least two amino acid sequences; fungicides for treating plant or human |
03/23/1999 | US5885577 Possess binding specificities that are similar to the binding specificities of the antibodies or receptors; may be used in place of antibodies in many assays or therapeutic applications |
03/18/1999 | WO1999013330A2 Purification of substances from a biological sample |
03/18/1999 | WO1999012975A1 Smart polymer-coupled bioactive entities and uses thereof |
03/18/1999 | WO1999012962A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
03/18/1999 | WO1998057672A3 Process for reducing the concentration of viral and molecular pathogens in a biological material |
03/18/1999 | DE19740770A1 Microfiltration layer for removing endotoxins from liquids |
03/18/1999 | DE19709752C1 Separator removing particles rapidly from fluid in e.g. biological, biochemical or medicinal fields |
03/18/1999 | CA2303462A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
03/17/1999 | EP0902034A2 Very large scale immobilized peptide synthesis |
03/17/1999 | EP0740792B1 Peptomers with enhanced immunogenicity |
03/17/1999 | EP0614465B1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
03/17/1999 | EP0549752B1 Protein sequencing |
03/16/1999 | US5884230 Method and system for protein modeling |
03/16/1999 | US5883256 Process for removing aromatic heterocyclic compounds product-containing solutions |
03/16/1999 | CA2019463C Antibiotics plusbacin |
03/16/1999 | CA1340447C Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them |
03/11/1999 | WO1999011656A1 Protein composition and process for isolating a protein composition from a muscle source |
03/11/1999 | WO1999011655A1 Modular protein libraries and methods of preparation |
03/11/1999 | WO1999011654A1 Randomly generated glycopeptide combinatorial libraries |
03/11/1999 | WO1999011590A1 Fluorination of proteins and peptides for f-18 positron emission tomography |
03/11/1999 | WO1999011294A1 Stable radioiodine conjugates and methods for their synthesis |
03/11/1999 | DE19739218A1 Aufreinigung von Substanzen aus einer biologischen Probe Purification of substances from a biological sample |
03/11/1999 | CA2302472A1 Randomly generated glycopeptide combinatorial libraries |
03/11/1999 | CA2301846A1 Modular protein libraries and methods of preparation |
03/10/1999 | EP0900285A1 Technique for representing combinatorial chemistry libraries resulting from selective combination of synthons |
03/10/1999 | CN1210559A Production of rDSPA 'alpha' I |
03/10/1999 | CN1210542A (N)-(3,3-dimethylbutyl)-L-aspartyl-D-'alpha' aminoalkanoic acid (N)-(S)-1-phenyl-1-alkanamide |
03/09/1999 | US5880972 Method and apparatus for generating and representing combinatorial chemistry libraries |
03/09/1999 | US5880273 Platelet activating factor acetylhydrolase, and gene thereof |
03/09/1999 | US5880265 Isolating factor viii and recombinants by anion exchange chromotography resulting in highly pure von willebrand factor having structural integrity, stability and no proteolytic degradation |
03/09/1999 | US5880259 Peptide useful as a ligand |
03/09/1999 | US5880119 Angiotensin converting enzyme inhibitors; analgesics, hypotensive agents, diuretics; treating congestive heart failure, irritable bowel syndrome |
03/09/1999 | US5880097 Tethered prodrugs |
03/09/1999 | US5880092 Conformationally stabilized cell adhesion peptides |
03/09/1999 | US5879686 Administering refolded trimeric meningococcal group b porin protein-polysaccharide conjugate to raise immune response in animal |
03/09/1999 | CA2038279C Cd25 binding molecules |
03/09/1999 | CA1340421C Sythesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method |
03/04/1999 | WO1999010370A1 A simple, environmentally benign, method for purifying protein a |
03/04/1999 | WO1999010016A1 Combinatorial library |
03/04/1999 | CA2341969A1 Combinatorial library |
03/03/1999 | EP0804474B1 Identification, quantitation and purification of insecticidal proteins from bacillus thuringiensis |
03/03/1999 | EP0595798B1 Bispecific heteroantibodies with dual effector functions |
03/03/1999 | EP0565590B1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
03/03/1999 | EP0537276B1 Cancer-associated scm-recognition factor, preparation and method of use |
03/03/1999 | CN1209437A Improved method for obtaining isulin precursor having correctly-bonded cystine bond |
03/03/1999 | CN1209435A Chinese trichosanthes protein, preparation method and use in pharmacy |
03/02/1999 | US5878373 System and method for determining three-dimensional structure of protein sequences |
03/02/1999 | US5877296 Reacting disulfide analogs of calicheamicin family with a carrier such as protein, peptide, mono and polyclonal antibodies, their antigen-recognizing fragments and chemically or genetically engineered counterparts |
03/02/1999 | US5877293 CDR grafted anti-CEA antibodies and their production |
03/02/1999 | US5877278 Solid phase synthesis using two submonomers-an acylating agent, e.g. a haloacetic acid, and a primary amine; cyclization to produce mimetics of drugs; elimination of the necessity of protection groups |
03/02/1999 | US5877152 Method for isolation of highly pure von Willebrand Factor |
03/02/1999 | US5876971 Amino acid sequence of protein isolated from insects which suck the blood of mammals; anticoagulants; treatment of thromboses or unstable angina or arteriosclerosis; prevention of reblockage of vessels after angioplasty |
03/02/1999 | US5876970 Expressing and recovering recombinantly produced surfactant protein-c, treating with activated derivative of fatty acid, thus forming fatty acid thioesters at cysteine residues; for stable, nonaggregating therapy for premature infants |
03/02/1999 | US5876968 Mixture of disulfide bonded dimer of al-milano, lipid lowering agent, and carrier; drug for treatment of athlerosclerosis and cardiovascular disease; prodrug for monomer; prevention of thrombosis |
03/02/1999 | US5876954 Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification |
03/02/1999 | US5876748 Drug delivery |
03/02/1999 | US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
02/25/1999 | WO1999009417A2 Method of drug selection |
02/25/1999 | WO1999009416A2 Method of drug selection |
02/25/1999 | WO1999009073A1 Solid phase supports |
02/25/1999 | WO1999009063A1 Interleukin-18 binding proteins, their preparation and use |
02/25/1999 | WO1999009052A1 Chemical modification of proteins to improve biocompatibility and bioactivity |
02/25/1999 | WO1999008869A1 Method and apparatus for controlled photoelution |
02/25/1999 | WO1999008699A1 Growth hormone secretagogues |
02/25/1999 | WO1998033808A3 A reversible stoichiometric process for conjugating biomolecules |
02/25/1999 | DE19736457A1 New super-potent human calcitonin analogues |
02/25/1999 | DE19735711A1 Insulin precursor |
02/25/1999 | CA2302467A1 Growth hormone secretagogues |
02/25/1999 | CA2300903A1 Method of drug selection |
02/25/1999 | CA2298855A1 Interleukin-18 binding proteins, their preparation and use |
02/24/1999 | EP0897983A2 Antibody against CD40-L |
02/24/1999 | EP0897928A1 Method for peptide synthesis |
02/24/1999 | EP0897390A1 Human tumor necrosis factor delta and epsilon |
02/24/1999 | EP0703900B1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES |